pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
TNG-260
Cervical Cancer
$TNGX
Tango Therapeutics, Inc.
0
catalysts
Phase 2
TNG-456
Bladder Cancer
$TNGX
Tango Therapeutics, Inc.
0
catalysts
Preclinical
TNX-1700
Colorectal Cancer
$TNXP
Tonix Pharmaceuticals Holding Corp.
0
catalysts
Phase 1
← prev
page 36 of 62
next →
131
Pain
89
Neurology
1
TORL-2307 MAB
Gastric Cancer
TORL Biotherapeutics LLC
0
catalysts
Phase 1
TP-317
Crohn's Disease (Regional Enteritis)
Thetis Pharmaceuticals LLC
0
catalysts
Phase 1
TPIV-110
Ductal Carcinoma In Situ
$MRKR
Marker Therapeutics, Inc.
0
catalysts
Phase 1
TPST-1495
Adenocarcinoma Of The Gastroesophageal Junction
$TPST
Tempest Therapeutics, Inc.
0
catalysts
Preclinical
TPST-3003
Refractory Multiple Myeloma
$TPST
Tempest Therapeutics, Inc.
0
catalysts
Phase 1
TRE-515
Ovarian Cancer
Trethera Corp
0
catalysts
pre_registration
TRGFT-201
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Orca Biosystems Inc
0
catalysts
Phase 2
TRI-611
Non-Small Cell Lung Cancer
TRIANA Biomedicines Inc
0
catalysts
Phase 2
TRK-950
Adenocarcinoma Of The Gastroesophageal Junction
Toray Industries Inc
0
catalysts
Phase 1
TRX-920
Unspecified Cancer
TaiRx Inc
0
catalysts
Phase 2
TSC-100
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$TCRX
TScan Therapeutics, Inc.
0
catalysts
Phase 2
TSC-101
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$TCRX
TScan Therapeutics, Inc.
0
catalysts
Phase 1
TSC-203 HLA-A*02:01
Head And Neck Cancer
$TCRX
TScan Therapeutics, Inc.
0
catalysts
Phase 1
TSN-084
Triple-Negative Breast Cancer (TNBC)
Tyligand Biotechnology (Shanghai) Co Ltd
0
catalysts
Phase 2
TSN-1611
Solid Tumor
Tyligand Biotechnology (Shanghai) Co Ltd
0
catalysts
Phase 2
TST-003
Metastatic Colorectal Cancer
Transcenta Holding Ltd
0
catalysts
Phase 1
TT-01488
Diffuse Large B-Cell Lymphoma
TransThera Sciences (Nanjing) Inc
0
catalysts
Phase 1
TT-125
Non-Small Cell Lung Cancer
TOLREMO Therapeutics AG
0
catalysts
Phase 1
TTC-352
Metastatic Breast Cancer
TTC Oncology LLC
0
catalysts
Phase 2
TTI-101
Metastatic Hepatocellular Carcinoma (HCC)
$TVRD
Tvardi Therapeutics, Inc.
0
catalysts
Phase 1
TTX-080
Acral Lentiginous Melanoma
Tizona Therapeutics Inc
0
catalysts
Preclinical
TTX-siPD-L1
Pancreatic Ductal Adenocarcinoma
$RNAZ
Transcode Therapeutics, Inc.
0
catalysts
Phase 2
TTXMC-138
Solid Tumor
$RNAZ
Transcode Therapeutics, Inc.
0
catalysts
Phase 2
TUB-040
Non-Small Cell Lung Cancer
Tubulis GmbH
0
catalysts
Phase 2
TVI-Kidney-1
Renal Cell Carcinoma
TVAX Biomedical Inc
0
catalysts
Preclinical
TY-0609
Breast Cancer
TYK Medicines Inc
0
catalysts
Preclinical
TYG-100
Gastrointestinal Tract Cancer
Tyg Oncology Ltd
0
catalysts
